TUESDAY AFTERNOON - SECTION A (9-AUG-22)

Pair 11 EW - LYNETTE JACKSON / MAX HAVERCROFT
Place: 8, Percentage: 47.12%
Board No vs Pr ContractLeadResult  Score  Matchpoints%   
Board 112: AVRYL ATKINS / INGRID FREDERICKS3D S8C9-110314%  
Board 212: AVRYL ATKINS / INGRID FREDERICKS3H N7C9-140836%  
Board 312: AVRYL ATKINS / INGRID FREDERICKS3S N7H8501777%  
Board 46: CHRISTINE SMITHAM / ALAN TOLLEY6C W2S12137022100%  
Board 56: CHRISTINE SMITHAM / ALAN TOLLEY3D WKH8-501045%  
Board 66: CHRISTINE SMITHAM / ALAN TOLLEY4SX WAD9-200314%  
Board 71: ROBERTA ALTMUNER / MARILYN ATKINS1H SQC52001359%  
Board 81: ROBERTA ALTMUNER / MARILYN ATKINS4H S9C10-420314%  
Board 91: ROBERTA ALTMUNER / MARILYN ATKINS4H SAH10-420523%  
Board 107: KATRINA WILL / JANE ADAMS4S N2H12-680836%  
Board 117: KATRINA WILL / JANE ADAMS5S E9C10-501464%  
Board 127: KATRINA WILL / JANE ADAMS4S N6C73002195%  
Board 132: JOHN FRZOP / DERMOTT DOHERTY2H WQC9140836%  
Board 142: JOHN FRZOP / DERMOTT DOHERTY4S S2C10-420627%  
Board 152: JOHN FRZOP / DERMOTT DOHERTY3C NAS72002195%  
Board 168: CAROLA NEUTGENS / MARIA CASOTTI3D W5S9110314%  
Board 178: CAROLA NEUTGENS / MARIA CASOTTI4S WAH7-150314%  
Board 188: CAROLA NEUTGENS / MARIA CASOTTI3NT WJS7-10029%  
Board 193: METKA AGREZ / SHIRLEY MANLEIN5H WJS116502091%  
Board 203: METKA AGREZ / SHIRLEY MANLEIN2D STH9-110627%  
Board 213: METKA AGREZ / SHIRLEY MANLEIN4S W3H8-100314%  
Board 229: VIVIENNE HOLLOWAY / DIANA NARDI2S E2S91402195%  
Board 239: VIVIENNE HOLLOWAY / DIANA NARDI5D WKS126201045%  
Board 249: VIVIENNE HOLLOWAY / DIANA NARDI3D WJS91101986%  
Board 2511: BEATA BIEGANSKI / CAROL FENSOME6D N3C115022100%  
Board 2611: BEATA BIEGANSKI / CAROL FENSOME4S N3H12-68029%  
Board 2711: BEATA BIEGANSKI / CAROL FENSOME1NT S3H8-12000%  
Board 285: DINO PARDINI / HEIDI NAUDE5S E2H124801255%  
Board 295: DINO PARDINI / HEIDI NAUDE3NT E5H8-1001045%  
Board 305: DINO PARDINI / HEIDI NAUDE3NT W4S94001673%  

Click on the Board Number to display that complete board, or click on a Pair to show that Pair's performance.

     Back to this session's results